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Estrogen receptor α (ERα) is expressed in tissues as diverse as brains and mammary glands. In breast cancer, ERα is a 
key regulator of tumor progression. Therefore, understanding what activates ERα is critical for cancer treatment in 
particular and cell biology in general. Using biochemical approaches and superresolution microscopy, we show that 
estrogen drives membrane ERα into endosomes in breast cancer cells and that its fate is determined by the presence of 
fibronectin (FN) in the extracellular matrix; it is trafficked to lysosomes in the absence of FN and avoids the lysosomal 
compartment in its presence. In this context, FN prolongs ERα half-life and strengthens its transcriptional activity. 
We show that ERα is associated with β1-integrin at the membrane, and this integrin follows the same endocytosis and 
subcellular trafficking pathway triggered by estrogen. Moreover, ERα+ vesicles are present within human breast tissues, and 
colocalization with β1-integrin is detected primarily in tumors. Our work unravels a key, clinically relevant mechanism of 
microenvironmental regulation of ERα signaling.
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Introduction
Estrogen receptor α (ERα) is a transcription factor present in dif-
ferent adult tissues such as mammary gland, ovaries, uterus, and 
brain (Couse et al., 1997; Han et al., 2013). It regulates cell prolif-
eration, migration, and survival. In the breast in particular, ERα 
controls mammary development and plays a key role in tumor 
growth. Therefore, understanding what regulates ERα activa-
tion and shutdown is fundamental for cell biology. ERα action 
can be blocked with tamoxifen (the most widely used selective 
ER modulator), although one third of breast cancer patients 
develop resistance, with ERα regaining activity (Nardone et 
al., 2015; Jeselsohn et al., 2017). The causes of this resistance 
are still unclear.
So far, the main proposed mechanism for ERα signaling shut-
down is estrogen-induced ERα degradation. Estrogen binding to 
ERα induces its nuclear translocation. Once in the nucleus, ERα 
binds to its target promoters and is then ubiquitylated and sub-
sequently degraded in cytosolic proteasomes. Therefore, ERα’s 
half-life decreases from 4 to 2 h in the presence of estrogens. 
The pool of ERα attached to the plasma membrane by reversible 
S-palmitoylation on cysteine 447 (Acconcia et al., 2005; Marino 
et al., 2006; Adlanmerini et al., 2014) has been suggested to follow 
different degradation dynamics (La Rosa et al., 2012). Whether 
membrane-bound ERα has transcriptional activity is still a mat-
ter of debate (Levin, 2009). Understanding how membrane 
and cytoplasmic ERα are regulated in breast cancer is crucial to 
develop strategies to overcome resistance to endocrine therapy.
The ECM plays a key role in cell fate, and evidence is accu-
mulating that it modulates response to therapy in breast cancer 
as well (Ghajar and Bissell, 2008; Correia and Bissell, 2012). We 
previously described that ECM components affect the response 
of breast cancer cells to tamoxifen (Pontiggia et al., 2012). In 
particular, we found that fibronectin (FN), which correlates 
with lower survival when levels are increased (Yao et al., 2007; 
Helleman et al., 2008), induces tamoxifen resistance in breast 
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cancer cells when bound to β1-integrin, its surface receptor. 
Therefore, we hypothesized that FN–β1-integrin pathway might 
have a direct effect on ERα signaling, modifying its response to 
hormone treatment.
We used two well-known cellular models of ERα-positive 
human breast adenocarcinoma: MCF7 and T47D. These cell lines 
have been widely used and validated for the study of ERα activ-
ity because primary culture of normal or tumor human breast 
tissues leads to the loss of ERα expression (Graham et al., 2009; 
Hines et al., 2016). We demonstrate that FN prolongs ERα half-
life and strengthens its transcriptional activity. Mechanistically, 
we show that upon treatment with 17β-estradiol (E2), membrane 
ERα is endocytosed and travels in these vesicles through the cyto-
plasm and into the nucleus. In the absence of FN, it is degraded in 
lysosomes after 60 min of treatment. When FN is present, these 
endosomes escape lysosomal degradation, and ERα is localized in 
RAB11+ vesicles, typically involved in recycling. Using superreso-
lution microscopy and coimmunoprecipitation assays, we found 
that ERα and β1-integrin colocalize at the plasma membrane and 
are endocytosed together after stimulation with E2. In these ves-
icles, β1-integrin is also degraded upon 60 min of treatment with 
E2, unless FN is present. We propose that FN-bound β1-integrin, 
following its recycling pathway, drags these ERα–β1-integrin+ 
vesicles back to the plasma membrane, thus bypassing the lyso-
somal compartment. We show that these endosomes are present 
in normal and tumor human breast tissues, although only tumor 
samples showed positive colocalization between ERα and β1-in-
tegrin. This indicates that the mechanism of ERα overactivation 
dependent on its association with FN–β1-integrin pathway would 
be particularly active within tumors. In light of these findings, 
we strongly suggest that a novel therapeutic strategy designed 
to interfere with the cross talk between FΝ and ERα signaling 
pathways would resensitize patients to endocrine therapy.
Results
FN modulates ERα degradation and transcriptional activity
Given that we have previously shown that FN induces resistance 
to anti-estrogenic therapy (Pontiggia et al., 2012), we wondered 
whether FN has a direct effect on ERα activity. Research on ERα 
activity and dynamics in culture is challenging because primary 
culture of ERα-positive normal tissues and tumors leads to the 
loss of ERα expression (Hines et al., 2016). Therefore, we used 
two well-characterized human ERα-positive breast adenocarci-
noma cell lines, MCF7 and T47D, that allowed us to modulate and 
study ERα regulation in culture. We first performed luciferase 
reporter assays with a construction that allowed us to measure 
ERα activity mediated by the estrogen response element (ERE). 
We found that, when cells are seeded on FN, this receptor has 
a stronger transcriptional activity in the presence of E2, com-
pared with its activity on the control substrate (BSA; Fig. 1 a). To 
study the mechanism through which FN regulates ERα activity, 
we analyzed the effect of FN on ERα degradation. We found that 
when cells are seeded on BSA, ERα completely localizes in the 
nucleus after 15 min of treatment with E2 (Fig. 1 b). Knowing that 
E2 triggers ERα degradation, reducing ERα mean expression after 
60 min (Reid et al., 2003), we increased the treatment time and 
found that as expected, total ERα levels drop after stimulation 
with E2 in cells seeded on BSA (Fig. 1 c). When cells are seeded on 
FN, ERα is also completely localized in the nucleus after 15 min 
of treatment with E2 (Fig. 1 d). However, we found that after a 
longer treatment with the hormone (>60 min), FN inhibits E2- 
induced ERα degradation (Fig. 1 e). We confirmed these observa-
tions by immunofluorescence, showing a more intense signal of 
nuclear ERα after treatment with E2 in cells seeded on FN com-
pared with BSA (Fig. S1, a and b). Similar results were obtained 
using T47D cells (Fig. S1, c–f). These data indicate that FN inhib-
its E2-stimulated ERα degradation. Of note, total ERα levels are 
increased when cells are seeded on FN even in the absence of E2, 
indicating that FN might also alter basal ERα degradation dynam-
ics (Reid et al., 2003). Interestingly, when we performed ultra-
centrifugation to separate cytoplasmic and membrane fractions, 
we observed that membrane ERα follows a dynamics similar to 
cytoplasmic ERα (Fig. S1, g–j).
Moreover, we further tested the effect of FN on ERα shuttling 
kinetics. As shown in Fig. 1 f, E2 stimulates ERα nuclear local-
ization, reaching its maximum after 8 min of treatment. These 
kinetics are not affected by the presence of FN (Fig. 1 g). However, 
upon 20 min of treatment, it can be already observed that degra-
dation of both nuclear and cytoplasmic ERα is reduced when cells 
are seeded on FN. Altogether, these data indicate that FN modu-
lates ERα degradation but does not alter ERα shuttling dynamics 
to the nucleus.
ERα is degraded in lysosomes and can be rescued by FN
We next tested whether FN was inhibiting E2-triggered proteaso-
mal degradation of ERα, the best-characterized degradation path-
way of this receptor. We found that upon E2 stimulation for 60 
min, inhibition of the proteasomal pathway with bortezomib (BZ) 
increases ERα levels even in the presence of FN (Fig. 2 a), suggest-
ing that FN would inhibit a different mechanism of ERα degrada-
tion. Because FN has been found to modulate lysosomal degrada-
tion of membrane proteins (Caswell et al., 2009; Dozynkiewicz 
et al., 2012), we next asked whether ERα could be degraded in 
lysosomes upon E2 stimulation. Blocking the passage of late endo-
somes to lysosomes by inhibiting V-ATPase with bafilomycin-A1 
(BAF; Li et al., 2013) impaired ERα degradation after 60 min of 
treatment with E2, in cells seeded on BSA (Fig. 2 b). To further test 
that ERα is degraded in lysosomes after E2 treatment, we expressed 
GFP-tagged Rab7, a well-known small GTPase that determines the 
passage of late endosomes to lysosomes (Vanlandingham and 
Ceresa, 2009). As shown in Fig. 2 c, E2 treatment triggers ERα 
colocalization with Rab7. Pearson’s and Manders’ correlation coef-
ficients (PCCs and MCCs, respectively) were used to quantify the 
degree of colocalization observed between these proteins in each 
analyzed field as previously described (Dunn et al., 2011). The 
overall significance level of colocalization was calculated from 
these coefficients for each condition. A shorter treatment with E2 
(15 min) revealed an increase in ERα localization closer to the Rab7 
compartment, although practically no colocalization with Rab7+ 
endosomes was observed (Fig. S1 k, top), indicating that a longer 
treatment is necessary for ERα+ vesicle localization to lysosomes.
We next investigated the effect of FN on E2-induced ERα lyso-
somal degradation and found that ERα does not colocalize with 
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Rab7 after 60 min (Fig. 2, e and f) or 15 min (Fig. S1 k, bottom) 
treatment in the presence of FN. These data indicate that FN is 
rescuing ERα from being degraded in the lysosomal compart-
ment. We confirmed these results with LAMP-1, a lysosomal 
marker, which shows that after 60 min of treatment with E2, ERα 
colocalizes with LAMP-1 when cells are seeded on BSA, and this 
is reverted when cells are seeded on FN (Fig. S1 l).
To ensure that ERα signals observed in these assays correspond 
in fact with ERα, we checked the specificity of this antibody. We 
used the epitope this antibody was raised against as a blocking 
peptide and obtained no ERα signal in Western blot or immuno-
fluorescence assays (Fig. S1, m and n). Moreover, knockdown of 
ERα significantly reduces the signal obtained with this antibody 
proving that it specifically recognizes this protein (Fig. S1 o).
ERα is rapidly endocytosed after estrogen treatment
We next asked whether ERα was present in endosomes that could 
end up in lysosomes upon E2 stimulation and whether this was 
Figure 1. FN stimulates ERα’s transcriptional 
activity. (a) Luciferase assay in MCF7 cells 
transiently transfected with pTK-ERE-Luc and 
pTK-Renilla, seeded on BSA or FN and treated for 
14 h as indicated. Data are represented as mean 
± SD. Differences between groups were analyzed 
by two-way ANO VA followed by Bonferroni con-
trasts adjusted for multiple comparisons (n = 3 
replicates). (b and c) Top: Western blot of a sub-
cellular fractionation of MCF7 cells seeded on 
BSA and treated for 15 min (b) or 60 min (c) as 
indicated. Blotting antibodies are shown on the 
left. Bottom: densitometry. For each subcellular 
fraction, shown is the ERα/β-actin density ratio 
normalized to the mean control group. Each 
symbol represents a different experiment. Differ-
ences between groups were analyzed by a one-
tailed paired Student’s t test (n = 3 replicates). 
(d and e) Top: Western blot of a subcellular frac-
tionation of MCF7 cells seeded on FN and treated 
for 15 (d) or 60 min (e) as indicated. Blotting anti-
bodies are shown on the left. Bottom: Densitom-
etry. For each subcellular fraction, shown is the 
ERα/β-actin density ratio normalized to the mean 
control group. Each symbol represents a differ-
ent experiment. (f) Western blot of the cytosolic 
+ membrane fraction of MCF7 cells seeded on 
BSA or FN and treated with E2 for the indicated 
times. Below the blots, the ERα/β-actin density 
ratio is shown, normalized to the control group. 
(g) Western blot of the nuclear fraction of MCF7 
cells seeded on BSA or FN and treated with E2 
for the indicated times. Below the blots, the ERα/
PCNA density ratio is shown, normalized to the 
control group. Differences between groups were 
analyzed by one-tailed paired Student’s t test (n 
= 3 replicates). *, P < 0.05; **, P < 0.01; ***, P < 
0.001. Shown data are representative of at least 
three independent experiments. Black arrow-
heads indicate positions of 50-kD markers. White 
arrowheads indicate positions of 37-kD markers. 
Treatments: ethanol (vehicle) or 10−8 M E2.
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an FN-induced event. We found that ERα is present in vesicle-like 
punctae after treatment with E2 for 15 min, regardless of the 
presence of FN (Fig. 3, a and b). To confirm that E2 was inducing 
rapid endocytosis in these cells, we stained them for EEA1, an 
early endosomal marker, and found that the size of EEA1+ vesicles 
is dramatically increased after a 15-min treatment with E2 (Fig. 3, 
c and d). Moreover, ERα colocalizes with EEA1 upon E2 treatment 
(Fig. S2 a). Interestingly, we found that EEA1+ endosomes are 
strongly localized in the nuclear membrane with this treatment 
(Fig. 3, e and f). We stained these cells with Lamin B1, a nuclear 
envelope marker, or with propidium iodide and performed 3D 
reconstructions to confirm that EEA1 colocalizes with Lamin B1, 
although EEA1+ endosomes do not seem to enter the nucleus (Fig. 
S2, b and c). This finding led us to hypothesize that these endo-
somes could be carrying ERα straight into the nucleus, where it 
would exert its action, analogous to the way signaling endosomes 
carry neurotransmitters along neuronal axons (Delcroix et al., 
2003; Cosker et al., 2008; Cosker and Segal, 2014). To investi-
gate whether nuclear localization of ERα was in fact endocytosis 
dependent, we studied the effects of low temperatures on ERα 
Figure 2. ERα is degraded in lysosomes and rescued by FN. (a) Top: Western blot of T47D cells seeded on BSA or FN pretreated with BZ 8nM or its vehicle 
(saline) for 4 h and treated as indicated. Bottom: Densitometry. For each subcellular fraction, the mean ERα/β-actin density ratio is shown normalized to the 
mean control group. (b) Top: Western blot of a subcellular fractionation of T47D cells pretreated for 90 min with 25 nM BAF or its vehicle (DMSO) and then 
treated for 60 min with 10−8 M E2 or its vehicle (ethanol). Blotting antibodies are shown on the left. Bottom: Densitometry. For each experimental condition, 
the ERα/β-actin density ratio is shown, normalized to the mean control group. Each symbol represents a different experiment. Differences between groups 
were analyzed by one-tailed paired Student’s t test (n = 3 replicates). (c) Confocal images of T47D cells expressing GFP-Rab7 seeded on BSA treated for 60 
min with vehicle or E2, and stained for ERα. In the inset, arrows indicate points of colocalization. (d) Quantification of c. For each experimental condition, 
Pearson’s correlation index and Manders’ coefficients (M1 and M2) were calculated within the areas of colocalization using Fiji. Data are represented as mean 
± SD. Differences between groups were analyzed by one-tailed Student’s t test (per replicate: Pearson’s: nvehicle = 11 fields, nE2 = 12 fields; Manders’: nvehicle 
= 8 fields, nE2 = 9 fields). (e) Confocal images of T47D cells expressing GFP-Rab7 seeded on FN treated for 60 min with vehicle or E2, and stained for ERα. 
(f) Quantification of e. For each experimental condition, Pearson’s correlation index and Manders’ coefficients (M1 and M2) were calculated within the areas 
of colocalization using Fiji. Data are represented as mean ± SD. Differences between groups were analyzed by one-tailed Student’s t test (per replicate: nvehicle 
= 9 fields, nE2 = 7 fields). Treatments: ethanol (vehicle) or 10−8 M E2, 8 nM BZ. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Shown data are representative of at least 
three independent experiments. Black arrowheads indicate positions of 50-kD markers. White arrowheads indicate positions of 37-kD markers. Bars, 10 µm 
(unless otherwise indicated).
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subcellular shuttling. This treatment should immediately block 
both membrane events: endocytosis and ATP-dependent vesicle 
trafficking (Letoha et al., 2003). We found that chilling cells to 0°C 
completely blocks subcellular shuttling of ERα (Fig. 3 g), which 
is consistent with a static plasma membrane. We confirmed that 
the effect of low temperatures was reversible because prechilling 
the cells does not affect ERα shuttling (Fig. S2 d).
There are two main mechanisms of integrin endocyto-
sis: clathrin dependent and clathrin independent (Mayor and 
Pagano, 2007). Among clathrin-independent mechanisms, the 
Figure 3. E2 stimulates endocytosis of vesicles containing ERα. (a) Confocal images of MCF7 cells seeded on BSA (left) or FN (right) treated for 15 min as 
indicated and stained for ERα. Arrows indicate ERα+ endosomes. (b) Quantification of a. For each experimental condition, structures of ∼200-nm diameter 
(10–15 pixels) were quantified using Fiji. Shown is the number of ERα+ puncta per cell. Differences between groups were analyzed by one-tailed Student’s 
t test (per replicate: BSA: nvehicle = 81 cells, nE2 = 87 cells; FN: nvehicle = 50 cells, nE2 = 64 cells). (c) Confocal images of MCF7 cells seeded on BSA (left) or FN 
(right) treated for 15 min as indicated and stained for EEA1. Cells are delineated in white. Arrows indicate early endosomes. (d) Quantification of c. For each 
experimental condition, shown is EEA1 intensity (mean gray value) per cell calculated using Fiji relative to the highest intensity recorded. Differences between 
groups were analyzed by one-tailed Student’s t test (per replicate: BSA: nEtOH = 68 cells; nE2 = 39 cells; FN: nEtOH = 94 cells; nE2 = 108 cells). (e) Confocal images 
of MCF7 cells seeded on FN treated for 15 min as indicated and stained for EEA1. Merges between differential interference contrast (DIC) microscopy and the 
green channel are shown. Arrows indicate early endosomes present either in the nuclear membrane or inside the nucleus. (f) Quantification of e. For each 
experimental condition, structures of 10–15 pixels in diameter were quantified using Fiji. Shown is the number of nuclear early endosomes per cell. It was cal-
culated as the total number of EEA1+ vesicles in the nuclear membrane or inside the nucleus, per cell. Differences between groups were analyzed by one-tailed 
Student’s t test (per replicate: nEtOH = 59 cells; nE2 = 54 cells). (g) Top: Outline of the protocol followed and Western blot of a subcellular fractionation of MCF7 
cells treated as indicated. Blotting antibodies are shown on the left. Bottom: Densitometry. For each subcellular fraction, shown is the ERα/β-actin density 
ratio normalized to the mean control group. Each symbol represents a different experiment. Differences between groups were analyzed by one-tailed paired 
Student’s t test (n = 3 replicates). (h) Top: Western blot of a subcellular fractionation of MCF7 cells treated for 15 min as indicated. Blotting antibodies are shown 
on the left. Bottom: Densitometry. For each subcellular fraction, shown is the ERα/β-actin density ratio normalized to the control group. Differences between 
groups were analyzed by one-tailed paired Student’s t test (n = 3 replicates). (i) Luciferase assay in MCF7 cells transiently transfected with pTK-ERE-Luc and 
pTK-Renilla and treated for 14 h as indicated. Differences between groups were analyzed by two-way ANO VA followed by Bonferroni contrasts adjusted for 
multiple comparisons (n = 3 replicates). Data are represented as mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Treatments: ethanol (vehicle) or 10−8 M E2, 
2.5 µg/ml filipin, 5 µM PAO. Shown data are representative of at least three independent experiments. Black arrowheads indicate positions of 50-kD markers. 
White arrowheads indicate positions of 37-kD markers. Bars, 10 µm.
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best described is the caveolin-dependent pathway. Given that ERα 
is known to interact with caveolin 1 and 3 (Schlegel et al., 1999; 
Chung et al., 2009), we hypothesized that ERα would be endocy-
tosed through a caveolin-dependent mechanism in the presence 
of E2. To test this, we used filipin, a specific inhibitor of caveo-
lin-mediated endocytosis/membrane recycling, and found that it 
inhibits E2-stimulated ERα nuclear translocation (Fig. 3 h). The 
inhibition of clathrin-mediated endocytosis with phenylarsine 
oxide (PAO) does not affect ERα shuttling dynamics (Fig. 3 h). 
We next assessed the effect of filipin treatment on ERα tran-
scriptional activity, performing luciferase reporter assays with 
a construction that allowed us to measure ERα activity mediated 
by the ERE. As expected, we found that E2 is not able to induce 
ERα transcriptional activity in the presence of filipin, support-
ing the finding that ERα endocytosis has a major effect in gene 
transcription (Fig. 3 i). We verified the specific action of filipin 
and PAO through the inhibition of their canonical endocytosis 
substrates (Fig. 4, a and b). Together with these results, we found 
that caveolin 1 colocalizes with EEA1 in the cytoplasm upon 15 
min of treatment with E2 (Fig. 4 c). We further tested the effect 
of caveolin 1 knockdown on ERα action and found that it inhib-
its ERα transcriptional activity, similarly to what we found with 
its pharmacological inhibitor (Fig. 4, d and e). Interestingly, we 
found that clathrin knockdown also impairs ERα transcriptional 
activity (Fig. 4, d and e). This suggests that clathrin might also 
play at least a partial role in ERα dynamics. Altogether, these data 
indicate that E2 induces caveolin-mediated ERα endocytosis in 
cells seeded on BSA or FN.
ERα+ colocalizes with Rab11 in the presence of FN
Internalized endosomes typically avoid lysosomal degradation 
if recycled to the plasma membrane (Gould and Lippincott-
Schwartz, 2009). Therefore, we explored whether FN pro-
moted the recycling of ERα+ endosomes, therefore inhibiting 
Figure 4. ERα is endocytosed through a caveolin 1–dependent pathway. (a) Top: Confocal images of MCF7 cells treated for 15 min as indicated and stained 
for caveolin 1. Bottom: Merge between caveolin 1 signal and differential interference contrast (DIC) images. Arrows indicate internal or peripheral localization 
of caveolin 1. (b) Top: Confocal images of MCF7 cells, treated for 15 min as indicated, and stained for clathrin. Bottom: Merge between caveolin 1 signal and DIC 
images. Arrows indicate internal or peripheral localization of clathrin. (c) Confocal images of MCF7 cells treated for 15 min as indicated and stained for caveolin 
1 or EEA1. Arrows indicate regions of colocalization between the two markers. (d) Western blots of MCF7 cells transfected with siRNAs against caveolin 1, 
clathrin HC, or scrambled for 48 h. Blotting antibodies are shown on the right. Fold change relative to scrambled siRNA is shown on the bottom. (e) Luciferase 
assay in MCF7 cells transiently transfected with pTK-ERE-Luc and pTK-Renilla and the respective siRNAs and treated for 14 h as indicated. Differences between 
groups were analyzed by two-way ANO VA followed by Bonferroni contrasts adjusted for multiple comparisons (n = 3 replicates). Data are represented as mean 
± SD. **, P < 0.01. Shown data are representative of at least three independent experiments performed. Treatments: ethanol (vehicle) or 10−8 M E2, 2.5 µg/ml 
filipin, 5 µM PAO. Bars, 10 µm.
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its lysosomal degradation induced by E2. We found that, when 
cells are seeded on FN and treated with E2 for 15 min, there is a 
larger proportion of ERα+ vesicles closer to the basal plane (ven-
tral membrane) than when cells are seeded on BSA as shown in 
Figs. 5 (a and b) and S2 e. Consistent with these findings, after a 
longer treatment with E2, ERα distribution in the cytoplasm is 
peripheral when cells are seeded on FN compared with a more 
centered distribution on BSA (Fig.  5  c). These data suggest 
that in the presence of FN, ERα+ vesicles are more likely to be 
found closer to the plasma membrane than to the lysosomal– 
perinuclear compartment.
To further explore whether ERα+ vesicles are more likely to 
be redirected to the plasma membrane in the presence of FN, 
we costained the cells with the recycling marker Rab11 (Grant 
and Donaldson, 2009). Rab11 is mostly localized in the perinu-
clear region and is further transported to the cell periphery to 
participate in membrane fusion when recycling is active (Cox et 
al., 2000; Takahashi et al., 2012). We found that the degree of 
colocalization of ERα with Rab11 is highest when cells are seeded 
on FN, particularly at the membrane tips, indicating that ERα is 
more likely to be localized in Rab11+ vesicles under these con-
ditions (Fig. 5, d and e). Together with this, overall intensity of 
Figure 5. ERα+ is localized in Rab11+ vesicles in the presence of FN. (a) Images of confocal microscopy of MCF7 cells seeded on BSA or FN treated for 15 
min as indicated and stained for ERα. Panels show the cytoplasmic/plasma membrane (basal) plane (z2). Nuclear/cytoplasmic (apical) plane (z1) is shown in Fig. 
S3 b. White arrows indicate ERα+ vesicles determined as punctae of 10–15 pixels in diameter (∼200 nm). (b) Quantification of a. Apical (nuclear/cytoplasmic) 
versus basal (cytoplasmic/plasma membrane) distribution of ERα+ vesicles. Structures of 10–15 pixels in diameter were quantified using Fiji. Mean number of 
endosomes in each fraction and for each condition is shown. (c) Heatmaps of T47D cells seeded on BSA or FN treated for 60 min as indicated and stained for 
ERα. Cells are outlined in white. Dashed line outlines the nucleus. Intensity bars are shown on the right (red, maximum pixel intensity; blue, minimum pixel 
intensity). Original images are shown in the insets. (d) Images of confocal microscopy of MCF7 cells seeded on BSA or FN treated for 60 min with E2 and stained 
for ERα and Rab11. Arrows indicate areas of colocalization within filopodia. Pearson’s colocalization maps are shown in the insets. (e) Quantification of d. For 
each experimental condition, Pearson’s correlation index was calculated within filopodia protrusions using Fiji. Differences between groups were analyzed by 
one-tailed Student’s t test (per replicate: nBSA = 16 fields, nFN = 15 fields). (f) Quantification of d. For each experimental condition, overall Rab11 intensity was 
calculated using Fiji. Data are represented as mean ± SD. Differences between groups were analyzed by one-tailed Student’s t test (per replicate: nBSA = 5 fields, 
nFN = 4 fields). (g) Images of confocal microscopy of MCF7 cells seeded on BSA or FN treated for 15 min with E2 in the presence of dextran-CF543 and stained 
for Rab11. Arrows indicate areas of colocalization between the two fluorophores. Higher magnification is shown in the inset. ***, P < 0.001. Shown data are 
representative of at least three independent experiments. Treatments: ethanol (vehicle) or 10−8 M E2. Bars, 10 µm (unless otherwise indicated).
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Rab11 is higher in the presence of FN, suggesting that this path-
way is enhanced either by the presence of more Rab11+ vesicles or 
by an increased size of these vesicles (Fig. 5, d and f).
We further tested the effect of E2 on endocytosis using dex-
tran (10 kD) conjugated with a red fluorophore. We found that 
a 15-min treatment with E2 induces strong dextran endocyto-
sis that also colocalizes with EEA1 (Fig. S2, f–h). In addition, we 
found that dextran colocalizes with Rab11 when cells are seeded 
on FN, suggesting that it is more frequently localized in Rab11+ 
vesicles in this condition (Fig. 5 g). Moreover, we measured the 
amount of dextran present in the supernatant after E2 treatment 
and found that it is significantly higher when cells are seeded on 
FN, further suggesting that dextran would be more likely to be 
recycled in the presence of FN (Fig. S2 i).
ERα is associated to β1-integrin in estrogen-
triggered endosomes
To gain insight into the possible mechanism responsible for 
triggering ERα localization in Rab11+ vesicles on cells seeded 
on FN after E2 treatment, we explored the possibility that upon 
endocytosis, ERα+ endosomes might contain integrins that, if 
engaged with FN, would trigger membrane recycling, therefore 
making the whole complex avoid lysosomal degradation (Caswell 
et al., 2009; Sung and Weaver, 2011; Dozynkiewicz et al., 2012; 
De Franceschi et al., 2015). Because we have previously found 
that FN-induced endocrine resistance is mediated by β1-integ-
rin (Pontiggia et al., 2012), we asked whether this could be the 
bona fide integrin associated with ERα at the plasma membrane 
and, therefore, present in E2-induced endosomes. We performed 
total internal reflection fluorescence microscopy (TIR FM), which 
allows the detection only of those fluorophores localized on the 
ventral plasma membrane, at the cell–substrate interphase. This 
assay showed that β1-integrin and ERα colocalize at the ventral 
membrane in MCF7 cells (Fig. 6, a and b; and Video 1). For β1-in-
tegrin detection, live-staining technique was used to intensely 
detect integrin present in the periphery of the cell, although it 
does not stain cytoplasmic integrin. Therefore, most of the colo-
calization structures were found at the periphery of the cell, 
where further colocalization analysis was run as described pre-
viously (Dunn et al., 2011). We also found colocalization struc-
tures in T47D cells (Fig. S3 a). As a positive control, colocaliza-
tion between β1-integrin and its well-known partner FAK was 
assayed with TIR FM, and a similar colocalization pattern was 
found (Fig. S3 b).
Consistent with these results, coimmunoprecipitation exper-
iments showed that ERα and β1-integrin immunoprecipitate 
together (Figs. 6 c and S3, c and d). Moreover, we found that 
β1-integrin has a sequence of five amino acids (LXX LL) within 
the cytoplasmic-proximal region of its transmembrane domain 
that is present among all steroid hormone receptor coactivators 
such as steroid receptor coactivator 1 (SRC1; Fig. 6 d; Mak et al., 
1999). Indeed, this conserved motif called NR-box is known to be 
sufficient to mediate the interaction of coactivators with nuclear 
receptors such as ERα. For ERα in particular, this interaction 
is established within its helix 12 in the AF-2 domain (Heery et 
al., 1997; Savkur and Burris, 2004). In addition, we found that 
only β1- and β3-integrins contain this sequence (Fig. 6 d), and 
remarkably, these two integrins share several extracellular 
ligands and moreover are known to have transmembrane and 
cytoplasmic domains that are functionally interchangeable 
(Solowska et al., 1991). Fig. 6 e shows our proposed model for 
ERα–β1-integrin interaction. Further analyses needed to con-
firm ERα–β1-integrin physical association are being conducted 
at our laboratory.
We further investigated whether β1-integrin followed the 
same endocytosis/degradation pathway as ERα. We found that 
as with ERα, 60-min treatment with E2 generates a strong reduc-
tion in β1-integrin levels (Figs. 6 f and S3 e). As shown in Fig. 5 f, 
E-cadherin levels remain unchanged after this treatment, indi-
cating that E2-induced endocytosis and posterior degradation is 
specific for certain plasma membrane proteins spatially associ-
ated with ERα. As expected, when cells were seeded on FN, this 
ECM protein rescued β1 integrin from E2-induced degradation 
(Figs. 6 g and S3 f).
Using the antibody feeding technique, we followed β1-integ-
rin internalization dynamics and found that 15-min treatment 
with E2 stimulates the internalization of β1-integrin (Fig. S3, g 
and h). This technique allows the detection of β1-integrin+ endo-
somes in a cleaner manner, making it possible to see a small frac-
tion of them without the background signal from cytoplasmic 
β1-integrin. Along with this, β1-integrin and ERα colocalize in 
a proportion of E2-induced endosomes (Fig. 6, h and i). More-
over, β1-integrin shows a strong colocalization with Rab11 after 
stimulation with E2 in cells plated on FN, indicating that as with 
ERα, β1-integrin is largely localized in Rab11+ vesicles under 
these conditions (Fig. 6, j and k). As another control, cells neg-
ative for ERα (such as MDA-MB-231) do not exhibit alterations 
in β1-integrin levels after prolonged treatment with E2 (Fig. S3, i 
and j), suggesting that E2-induced β1-integrin degradation is in 
fact mediated by ERα.
Estrogen treatment stimulates ERα–β1-integrin clustering
To investigate the interaction between ERα and β1-integrin in 
higher detail, we performed two-color superresolution micros-
copy using stochastic optical reconstruction microscopy (STO 
RM; Rust et al., 2006; Bates et al., 2007). Fig.  7  a shows rep-
resentative STO RM images taken in regions of the filopodia 
of MCF7 cells.
Two-color STO RM is a fairly new technique, and therefore 
there is no consensus yet on the optimal method to quantify cor-
relations between biomolecules. PCC or MCC indices have been 
used to measure the degree of cooccurrence of the two colors in 
the same pixel within very small areas of the image where phys-
ical colocalization happens (He et al., 2015; Johnson et al., 2016). 
In principle, the changes in the association between any pair 
of biomolecules can be estimated by three pairwise quantities: 
mutual distances between their domains, relative densities, and 
spatial heterogeneity. We started by analyzing the images using 
a recently published method (Bermudez-Hernandez et al., 2017) 
that accounts for two of these quantities: mutual distances and 
densities. Fig. 7 b shows the results for this interaction factor (IF) 
between β1-integrin and ERα calculated for control and treated 
cells. As shown by this index, there are regions with low colocal-
ization (<0.1) and others with higher correlation (>0.4). In fact, 
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Figure 6. ERα is spatially associated with β1-integrin and they are endocytosed together. (a) Widefield (top) and TIR FM (bottom) images of a coim-
munofluorescence in MCF7 cells, using antibodies against β1-integrin (live-stained) and ERα. In the inset, white arrowheads indicate points of colocaliza-
tion. Pearson’s correlation maps corresponding with the white box shown on the right. White arrowheads indicate points of positive Pearson’s correlation. 
(b) Quantification of a. Top left: Polar transformation of TIR FM images was performed using Fiji to align areas of the cell periphery where colocalization is 
found. For each experimental condition, Pearson’s correlation index and Manders’ coefficients (M1 and M2) were calculated within the areas of colocalization 
(ROI) and compared with random areas without colocalization (Null), using Fiji. For Pearson’s correlation, datasets are plotted and mean ± SD are shown on 
the graph. For Manders’ coefficients, the table shows mean and SD for each dataset. Differences between groups were analyzed by one-tailed Student’s t test 
(per replicate: Pearson’s: nnull = 9 fields, nROI = 9 fields; Manders’: nnull = 14 fields, nROI = 9 fields). (c) Western blot of a coimmunoprecipitation in MCF7 cells, 
using antibodies against β1-integrin or ERα. Blotting antibodies are shown on the right. Input, whole lysate. IP, immunoprecipitated fraction. (d) ClustalW 
alignment of the eight β-integrins present in humans. The sequence of SRC1 is shown on top. NR-box motif is indicated in red. On the sequences of β1-integrin 
and β3-integrin, underlined in black is the region corresponding with their transmembrane domain, and in green is their cytoplasmic domain. The topology was 
predicted using the algorithm TMpred from the website ExPASy and the algorithm from the website TOP CONS. (e) Cartoon showing β1-integrin structure and 
putative interaction site with ERα. Black box indicates the localization of NR-box motif (LXX LL) within β1-integrin transmembrane domain. Red dot shows ERα 
palmitoylation site, and the arrow indicates where its helix 12 would be localized within the AF-2 domain. (f and g) Top: Western blot of total lysates of MCF7 
cells, seeded on BSA (f) or FN (g) and treated for 60 min as indicated. Blotting antibodies are shown on the left. Bottom: Densitometry. For each experimental 
condition, shown is the β1-integrin/β-actin density ratio normalized to the mean control group. Each symbol represents a different experiment. Differences 
between groups were analyzed by one-tailed paired Student’s t test (n = 3 replicates). (h) Confocal images of MCF7 cells treated for 15 min as indicated and 
stained for β1-integrin (live stained) and ERα. Arrows indicate points of colocalization. Corresponding Pearson’s correlation maps are shown on the right, 
respectively. White arrows indicate points of positive Pearson’s correlation. (i) Quantification of h. For each experimental condition, Pearson’s correlation index 
and Manders’ coefficients (M1 and M2) were calculated within the areas of colocalization (ROI) and compared with random areas without colocalization (Null) 
using Fiji. For Pearson’s correlation, datasets are plotted and mean ± SD are shown on the graph. For Manders’ coefficients, the table shows mean and SD for 
each dataset. Differences between groups were analyzed by one-tailed Student’s t test (per replicate: Pearson’s: nnull = 14 fields, nROI = 15 fields; Manders’: nnull 
= 10 fields, nROI = 11 fields). (j) Confocal images of MCF7 cells seeded on BSA or FN treated with E2 for 15 min and stained for β1-integrin and Rab11. Full images 
are shown in the insets. (k) Quantification of j. For each experimental condition, Pearson’s correlation index was calculated within the areas of colocalization 
using Fiji. Data are represented as mean ± SD. Differences between groups were analyzed by a one-tailed Student’s t test (per replicate: nBSA = 4 fields, nFN = 4 
fields). *, P < 0.05; **, P < 0.01; ***, P < 0.001. Shown data are representative of at least three independent experiments. Black arrowheads indicate positions of 
100-kD markers. White arrowheads indicate positions of 50-kD markers. Treatments: ethanol (vehicle) or 10−8 M E2. Bars, 10 µm (unless otherwise indicated).
Sampayo et al. 
Fibronectin regulates estrogen receptor dynamics
Journal of Cell Biology
https://doi.org/10.1083/jcb.201703037
10
Figure 7. Effect of E2 treatment on the conditional distribution of ERα versus β1-integrin. (a) Images from STO RM of filopodia of MCF7 cells treated 
as indicated for 15 min and stained for ERα or β1-integrin. Insets in the top left corners show the same images taken with widefield microscopy. Inside the 
zoomed areas, arrows show regions of superposition of the two markers (yellow pixels). Blue squares outline representative areas of 500 × 500 pixels used for 
subsequent analyses. In the treated cell, arrow inside the blue square shows a region of dense clustering between ERα and β1-integrin. (b) Tables showing the 
IF calculated as described previously (Bermudez-Hernandez et al., 2017) for 10 representative frames of filopodia of MCF7 cells under control (top) or treated 
(bottom) conditions. R-G, red–green correlation; G-R, green–red correlation. Red, β1-integrin; green, ERα. (c) IF calculated for one treated cell (frame 7) and for 
two sub-ROIs of this frame, showing how this index changes between areas of different β1-integrin/ERα densities. Bars 2 µm. (d) Histogram for normalized 
frequencies of MD between β1-integrin and ERα in filopodia of MCF7 cells among all the analyzed frames for each condition. For each domain detected, cen-
troids were identified, and MDs were calculated from each β1-integrin to its nearest ERα domain throughout each 500 × 500–pixel frame. Frequencies were 
normalized to the highest value. The graph shows a slight shift toward smaller MDs for treated cells. (e) Mean density covariance between ERα and β1-integrin 
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this method shows a high variability depending on where the 
region of interest (ROI) is chosen as shown in Fig. 7 c. Therefore, 
based on this IF, one conclusion would be that there is no differ-
ence between control and treated cells, ignoring any change in 
β1-integrin/ERα clustering that could have occurred in specific 
domains of the filopodia of these cells. Indeed, this index, simi-
larly to PCCs and MCCs, is biased toward studying the cooccur-
rence of the two colors in the same pixel, which makes sense for 
diffraction-limited microscopy but is not enough for the resolu-
tion that STO RM offers (20–30 nm).
This calls for alternative ways to incorporate the heterogene-
ities of the distribution of the proteins in this analysis. There-
fore, we implemented a numerical estimation of the changes in 
the three quantities to describe the interaction between ERα and 
β1-integrin. To facilitate the analysis, these calculations were 
done using only the centroids of each domain, a simplification 
further justified by the fact that the sizes of the domains of both 
proteins were shown to be invariant between the different con-
ditions analyzed (see Fig. S4 e).
Of the three pairwise quantities, the simplest one is the esti-
mation of the minimum distance (MD) calculated over all pairs 
of ERα and β1-integrin molecules. The first analyses from these 
datasets reveal that the overall mean MD between ERα and β1- 
integrin is ∼100 nm (Fig. S4 a), clearly below the diffraction limit. 
This indicates that these molecules are probably part of the same 
subcellular nanodomain and that their localization is not well 
resolved by conventional diffraction-limited microscopy. Using 
this approach, we also investigated whether distribution of ERα 
and β1-integrin was affected by 15-min treatment with E2. Overall, 
of all frames, we found a small shift toward smaller MD for treated 
cells (Fig. 7 d). However, when comparing individual frames, we 
observed that this shift was in the other direction in three of the 
10 treated frames analyzed, suggesting that this overall difference 
is not significant and is highly dependent on the analyzed frame.
The second pairwise quantity estimates the covariation of 
densities, which is computed as the number of domains per unit 
area (for each ERα and β1-integrin). The functional association 
of these two molecules was investigated by computing their 
covariation as a function of increasing areas. The densities of the 
two proteins in fact covary, denoted by a positive linear regres-
sion coefficient between their densities as shown on the graph of 
Fig. S4 b. This covariation is shown to be statistically significant 
when tested against a null model constructed by randomizing 
the spatial positions of the centroids. This indicates that ERα and 
β1-integrin exhibit some degree of spatial cooccurrence and that 
such localization cannot be simply attributed to a random pro-
cess (as indicated by the values of the z scores in the inset in Fig. 
S4 b). With this tool, we further sought to explore whether the 
density covariance was influenced by E2 treatment. In this case, 
we found no significant difference between control and treated 
cells (Fig. 7 e).
Finally, the third analysis considers the spatial spread of both 
molecules, which seems highly heterogeneous. Specifically, we 
computed the ratio between the two densities (number of ERα 
centroids over number of β1-integrin centroids) inside a square 
ROI of a given size. An example of that heterogeneity is presented 
(for ROI side length = 50 nm) in Fig. S4 c. The revealed heteroge-
neity calls for caution when reporting overall means because they 
might not be representative of changes that are very important 
in one cell but negligible in others. For that reason, we decided 
to explore a novel measure with the potential to avoid the limita-
tions. The idea is very simple and uses a Voronoi transformation 
of the ERα receptor centroid positions (Nicovich et al., 2017). This 
mathematical transformation identifies a “shell” containing all 
the points in space that are closer to a given ERα protein than 
to any other ERα protein. After the transformation, the analysis 
estimates the size of the shells as well as their β1-integrin con-
tents, i.e., the number, distance, and distribution of β1-integrin 
centroids inside each shell.
Two examples of the Voronoi transformation (control and 
treated cells) are presented in Fig. 7 f, where the size of the shells 
are labeled with colors: centroids of each ERα domain with empty 
circles and locations of the β1-integrin centroids with full black 
circles. For each frame, we computed in each shell the average dis-
tance (AD) of all β1-integrins to the ERα centroid (notice that this 
is different from the previous computation that only accounted 
domains. Each frame was divided into square ROI of different sizes (window lengths ranging from 130 nm [10 pixels] to 2,000 nm [150 pixels] in side length). 
For each ROI size, the densities of ERα and β1-integrin were obtained, and the correlation coefficient (C) between these densities was calculated for all datasets. 
The mean of C among all the control (black full circles) or treated (pink empty squares) cells was plotted as a function of the window side length. Light-blue 
crosses show the z score (defined by the difference between the mean of the control group (for each window) and the mean of the treated group, and further 
divided by the square root of the sum of the SD of each group normalized by n). Thus, because the z score expresses, in units of SD, the distance between the 
two distributions, one may safely conclude that here there is no significant difference in density covariance between control and treated cells. (f) Two examples 
of a Voronoi partition for control (left) or treated (right) cells using the centroids of the ERα domains to compute the transformation. Colors indicated in the 
color bar on the right represent the size of each Voronoi shell (in square nanometers). Black small dots indicate the location of the centroids for β1-integrin 
domains. Empty big circles indicate the centroids of ERα domains; red circles denote those ERα that have β1-integrins closer than 160 nm, and blue circles 
indicate those ERα that have β1-integrins further than 160 nm away on the mean. The examples in these panels reveal a clear difference in ERα–β1-integrin 
bunching between control and treated conditions. (g) Histogram of frequencies for the ADs from each ERα centroid to the β1-integrins inside its Voronoi shell 
among all the analyzed data for each condition (note the semilog axis for presentation purposes). The graph shows a shift toward smaller distances for treated 
cells. Green arrows indicate as an example a region of the plot where the difference between treated and control fields is almost double. The inset shows the 
histogram for frequencies of the areas of the Voronoi regions among all the analyzed fields for each condition, demonstrating that treated cells present also 
relatively smaller Voronoi shells. (h) Graph of the bunching index for each cell, which is the ratio between the number of shells (normalized) that contains mean 
ERα–β1-integrin distances smaller than a threshold value of 160 nm. We named it bunching index as it quantifies the proportion of ERα–β1-integrin complexes 
among all the domains localized. Control image 1 and E2-treated image 4 are the ones represented in f. Inset shows the z score, which was calculated as the 
difference between each bunching index for the treated cell and the mean of the bunching indexes for the control group divided by the SD of the control group. 
Z score results demonstrate for six cells a significant difference (abs[z score] >1) in the bunching index between control and treated cells. In all plots, control 
cells are represented with black full circles and treated cells with pink empty squares. Treatments: ethanol (vehicle) or 10−8 M E2.
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for the MD). From the analysis of such transformations, we found 
that the AD of all β1-integrins to their corresponding ERαs inside 
each shell is different between control and treated cells. This is 
shown in Fig.  7  g, where the AD distributions for vehicle and 
treatment are plotted. Note that for relatively long AD values, 
the two estimations are similar; however, shorter ADs are more 
frequent for the treated cells than for the control ones. In other 
words, despite the heterogeneity, there are more ERαs having at 
least one β1-integrin close by. In particular, the region between 
50 and 300 nm of ERα-to–β1-integrin distances shows the most 
significant shift between control and treated cells, revealing that 
these distances are more frequent after a 15-min treatment with 
E2. These distances are compatible with the typical sizes of early 
endosomes (Luzio et al., 2007; Su et al., 2016), which further sup-
ports our data showing that ERα and β1-integrin are internalized 
upon E2 treatment. In addition, the sizes of Voronoi shells are also 
reduced by E2 treatment, suggesting that ERs are more tightly 
packed together (Fig. 7 g, inset).
To account for the observed heterogeneity between differ-
ent trials, particularly in treated cells, we developed an index to 
measure the statistical relevance of the differences between the 
mean of the control group and each treated cell individually, in 
that way revealing the intrinsic differences between treated ones 
(Fig. 7 h). We computed the ratio of Voronoi shells containing 
an AD less than a threshold value (we chose 160 nm, suggested 
by the mode value of AD in Fig. 7 g and also related to the most 
frequent size of early endosomes between 100 and 200 nm) over 
the total number of shells. This index, termed “bunching index,” 
is supposed to reflect for each experiment the tendency seen in 
Fig. 7 g for short distances.
As Fig. 7 h shows, a number of treated cells present a signifi-
cantly higher bunching index than the control ones. Interest-
ingly, there are a couple of E2-treated cells that showed the oppo-
site effect. This could represent the different kinetics with which 
each cell responds to E2. After E2 treatment, ERα–β1-integrin 
clustering that can be observed in most of the treated cells would 
be the first step preceding caveolin-dependent internalization as 
has been extensively shown previously (Mayor et al., 1994; Upla 
et al., 2004; Bacia et al., 2005). Conversely, faster-responding 
cells might have already internalized most of the endosomes 
containing ERα–β1-integrin clusters that would therefore not be 
present anymore in the membrane region analyzed, explaining 
why some treated cells showed fewer ERα–β1-integrin clusters 
than control ones.
Moreover, we studied whether size or number of ERα or β1-in-
tegrin domains were affected by the treatment and found there 
is no significant effect on these variables (Fig. S4, d–f). Interest-
ingly, sizes of these domains are scale free, i.e., they are well rep-
resented by a power law distribution, as often happens in many 
biological systems (Fig. S4 e; Honerkamp-Smith et al., 2009). We 
also verified that STO RM clearly reveals nuclear accumulation of 
ERα upon E2 treatment as shown in Fig. S5 (a and b).
ERα–β1-integrin complexes are present in tumor and 
normal human samples
To further explore whether ERα endocytosis takes place within 
human tissues, we analyzed normal human tissues from 
reduction mammoplasties and tumor samples from patients 
with mammary adenocarcinoma. We found that ERα is pres-
ent in endosome-like bodies in both normal and tumor samples 
(Fig. 8, a and b). Sizes of the vesicles observed are compatible 
with early endosomal vesicles (<500 nm), late endosomes (>600 
nm), or multivesicular bodies (>1 µm; Luzio et al., 2007; Su et 
al., 2016). We confirmed these observations using the ERα anti-
body typically used for clinical analysis (clone SP1) to stain dif-
ferent sections of the same samples used in Fig. 8 a. This anti-
body reveals ERα+ endosomes in both normal and tumor tissues 
(Fig. S5, c and d).
Interestingly, ERα colocalizes with β1-integrin in several 
areas of the analyzed tumor samples, showing a higher degree 
of colocalization compared with normal tissues (Fig.  8, a and 
c). Remarkably, membrane localization of ERα in the tumor 
samples is higher than in normal tissues; this might account 
for the increased degree of colocalization with β1-integrin 
within these samples.
To further explore the clinical relevance of ERα–β1-integrin 
association, we analyzed TCGA data through cBioPortal (Cerami 
et al., 2012; Gao et al., 2013) and found that alterations in ERα 
(ESR1) and β1-integrin (ITGB1) genes present a tendency to 
be mutually exclusive in breast cancer (Fig. 8 d). As has been 
intensely studied, alterations that affect the same pathway 
tend to not co-occur in the same patient (Cancer Genome Atlas 
Network, 2012; Ciriello et al., 2012). Therefore, mutual exclusiv-
ity would be further evidence indicating that ERα and β1-integ-
rin signaling have a close relationship. Moreover, breast cancer 
patients with genetic alterations in ESR1 or ITGB1 have decreased 
survival (Fig. 8 e).
These preliminary clinical findings reveal that even though 
ERα+ vesicles are present in both normal and tumor tissues, ERα 
and β1-integrin might only be co-endocytosed within tumors. 
Therefore, FN-induced strengthening of ERα signaling would be 
a tumor-specific phenomenon, which further suggests this path-
way as a target for new antitumor therapies.
Discussion
In this study, we demonstrate by biochemical approaches and 
high-resolution microscopy that E2 induces endocytosis of ERα 
by a mechanism involving caveolin 1. In the presence of FN, ERα 
avoids lysosomal degradation and is localized in Rab11+ recycling 
endosomes. We found that ERα is functionally associated with 
β1-integrin at the plasma membrane of breast tumor cells. We 
show that β1-integrin follows the same endocytosis/degradation 
dynamics in the presence of E2 and would be responsible for 
dragging ERα to Rab11+ vesicles in the presence of FN, avoiding 
lysosomal degradation. In this context, FN has a direct, positive 
impact on ERα’s transcriptional activity. ERα+ vesicles are present 
within human breast tissues, and colocalization with β1-integrin 
is detected primarily in tumors. The mechanism we describe in 
this study unravels a new level of regulation of cancer cell signal-
ing by the ECM and provides a putative target for new treatments 
directed to resensitize patients to endocrine therapy.
We found that upon E2 treatment, activated membrane ERα 
is endocytosed in a caveolin-dependent manner and travels in 
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Figure 8. Endosomes containing ERα are present in normal and tumor human breast tissues. (a) Top: Confocal images of a normal human breast tissue 
(reduction mammoplasty; sample N211) stained for ERα (HC-20 clone), β1-integrin, and DAPI. In the inset, arrows indicate the presence of ERα+ endosomes. 
Similar results were obtained in the four different specimens analyzed. Bottom: Confocal images of a human breast tumor (Luminal A subtype adenocarcinoma; 
sample T171) stained for ERα (HC-20 clone), β1-integrin, and DAPI. Yellow arrows indicate ERα+ endosomes. In the inset, arrows indicate the presence of ERα+ 
endosomes. Similar results were obtained in the three different specimens analyzed. (b) Magnification from the inset shown in panel a (top). Diameters of 
ER+ vesicles are shown on the right. (c) Table showing mean and SD of Pearson’s correlation index calculated for the overall colocalization between ERα and 
β1-integrin. Differences between groups were analyzed by two-tailed Student’s t test (per replicate: nnormal = six fields; ntumor = seven fields). (d) OncoPrint from 
http:// www .cbioportal .org (Cerami et al., 2012; Gao et al., 2013) showing the alterations found in ERα (ESR1) and β1-integrin (ITGB1) genes in different patients 
obtained from the search in four different datasets: British Columbia, Nature 2014 (Eirew et al., 2015); TCGA, Nature 2012 (Cancer Genome Atlas Network, 2012); 
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endosomes through the cytoplasm and into the nucleus. In addi-
tion, inhibition of clathrin also impairs ERα transcriptional 
activity, suggesting that the clathrin-dependent pathway might 
be also, at least partially, involved in ERα endocytosis. The shut-
tling of plasma membrane proteins into the nucleus through 
endosomes has been described for other endosomal proteins 
(Chaumet et al., 2015) and transmembrane receptors such as 
FGF (Małecki et al., 2004). A mechanism for E2-induced ERα 
endocytosis has been proposed for ERα-positive neurons (Kisler 
et al., 2013). We propose that binding of E2 to ERα would occur at 
the plasma membrane so that at least a proportion of hormones 
could exert their action without actually crossing through the 
membrane. We show in this study that E2-induced endosomes 
containing ERα can also be targeted to lysosomes, where ERα 
is degraded. Therefore, we propose that E2-induced lysosomal 
degradation of ERα is a relevant mechanism of desensitization 
to E2. However, this mechanism is lost when cells are in a FN-rich 
matrix, where ERα escapes lysosomal degradation and its tran-
scriptional activity is enhanced. We present evidence indicating 
that FN promotes ERα localization in Rab11+ vesicles that would 
therefore inhibit its lysosomal degradation.
As with other membrane proteins such as caveolin 1 and 
membrane-associated proteins such as integrin-linked kinase 
(Schlegel et al., 1999; Acconcia et al., 2006; Chung et al., 2009), 
ERα colocalizes with β1-integrin in plasma membrane structures. 
Through high-resolution microscopy and coimmunoprecipita-
tion analyses, we show evidence of a close association between 
these proteins that would be mediated by the NR-box that we 
identified within the β1-integrin sequence. Ongoing experiments 
in our laboratory are aiming to confirm the physical association 
between these two proteins and the domains involved.
Through STO RM superresolution microscopy, we showed that 
ERα and β1-integrin are present in the same nanodomains within 
the filopodia and, moreover, are organized in structures of size 
consistent with early endosomes. In addition, STO RM revealed 
that ERα–β1-integrin clustering is incremented upon E2 treat-
ment, further supporting the presented evidence that indicates 
that ERα–β1-integrin complexes are endocytosed together upon 
E2 treatment. Membrane β1-integrin could be in both its active 
(high-affinity) or inactive (low-affinity) conformations, each of 
which normally undergo different endocytosis/recycling path-
ways (De Franceschi et al., 2015). Inactive β1-integrins are rap-
idly recycled to the cell membrane to form protrusions such as 
lamellipodia and filopodia, following a fast recycling pathway. 
Active β1-integrins are less efficiently recycled and are targeted 
to the Rab7 compartment (Arjonen et al., 2012). However, in the 
presence of FN, ligand-occupied active β1-integrins are rapidly 
recycled from the lysosomal compartment to the rear of the cell, 
keeping their active conformation. Interestingly, this process 
occurs specifically in cancer cells and is a way by which cells 
remodel their ECM (Dozynkiewicz et al., 2012). Therefore, we 
propose that E2 induces internalization of at least active β1-in-
tegrins associated with ERα (Fig. 9). In the absence of FN, active 
β1-integrin and ERα are directed to the lysosomal compartment, 
where both proteins are degraded. However, when FN is pres-
ent, ligand-occupied active β1-integrin would be recycled to the 
plasma membrane in Rab11+ vesicles, carrying ERα with it and 
inhibiting its lysosomal degradation (Fig. 9). The role of integrins 
as masters of endosomal trafficking has been also demonstrated 
for other receptors and cargos such as VEG FR2 and lipid rafts 
(Caswell et al., 2009). In this context, an FN-rich matrix rep-
resents a double advantage for breast tumor cell survival because 
it triggers proliferative signals transduced through β1-integrin 
(Han and Roman, 2006; Moreno-Layseca and Streuli, 2014) and 
also intensifies E2 signaling. Ongoing experiments in our lab-
oratory are aiming to determine whether E2 affects active and 
inactive β1-integrins differently.
Several functions have been associated with membrane ERα 
and are mainly related to nonclassic (extranuclear) ERα signaling 
pathways (Levin, 2009). However, some authors have begun to 
suggest that there is a direct link between membrane ERα and its 
classic nuclear activity (Pedram et al., 2002; La Rosa et al., 2012). 
Our results provide a link between genomic and nongenomic 
effects of E2 through the activity of membrane-bound ERα. We 
show evidence suggesting that membrane ERα travels in endo-
somes into the nucleus, where it would also have transcriptional 
(genomic) activity. The evidence of the signaling pathway shown 
in this study is, to our knowledge, the first demonstration of the 
previously suggested hypothesis of an active mechanism respon-
sible for E2 shuttling into the nucleus (Pietras and Szego, 1984; 
Razandi et al., 2002). Further analyses are needed to unravel 
whether membrane ERα dimerizes within these endosomes and 
at which stage of its subcellular shuttling.
Endocytosis and subsequent degradation of ERα in lysosomes 
described in this study is a novel pathway of subcellular signal-
ing and negative feedback induced by E2. Totta et al. (2014, 2015) 
recently proposed that membrane-bound ERα could be degraded 
in lysosomes as well as in the proteasomal compartment. How-
ever, the authors did not demonstrate what membrane events 
take place in response to E2, leading to ERα internalization and 
further lysosomal degradation. In this study, we show robust 
evidence of this phenomenon, describing how this process is 
regulated and what is the response of the membrane proteins 
involved. However, it still remains to be elucidated how ERα 
enters the lysosomal lumen for its degradation. In this sense, 
it has been proposed that the molecular pump LAMP-2, which 
has been shown to interact with ERα, would be responsible for 
allowing its uptake into the lysosomal lumen (Totta et al., 2014; 
Wang and Robbins, 2014). The signal that triggers ERα lysosomal 
degradation after prolonged exposure to E2 and whether this 
mechanism requires ERα’s previous translocation to the nucleus 
are still unknown.
TCGA, Cell 2015 (Ciriello et al., 2015); and Nature 2012 and Nature Communications 2016 (Pereira et al., 2016). (e) Kaplan–Meier plot of the overall survival of 
patients with alterations in ESR1 or ITGB1 genes using thelargest and newest dataset available in http:// www .cbioportal .org (Breast Cancer-MET ABR IC; Cerami 
et al., 2012; Gao et al., 2013). Significance level after the log-rank test is shown in the plot. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Bars, 20 µm (unless other-
wise indicated). The results shown in this study are in whole or part based on data generated by the TCGA Research Network: http:// cancergenome .nih .gov/ .
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The finding that FN strengthens ERα activity suggests that 
tumor-like stromas would enhance ERα’s activity. FN has been 
shown to be incremented within cancer cells (Nam et al., 2010; 
Bae et al., 2013) and is known to contact breast epithelial cells 
when the normal structure of the basement membrane is dis-
rupted, which occurs during malignant transformation (Ghajar 
and Bissell, 2008; Lu et al., 2011, 2012). Within tumors, not only 
ECM composition changes but also its stiffness (Acerbi et al., 
2015). Therefore, it is tempting to speculate that not only the 
presence of FN but also the distorted tissue architecture in stiff 
substrates (i.e., more cell-substrate contacts, loss of cell api-
cal-basal polarity) might affect ERα degradation in tumors. The 
loss of normal cellular polarity and subcellular compartmental-
ization might lead to a different frequency of ERα–β1-integrin 
interactions in tumor cells. Indeed, we show that although ERα+ 
endosomes are present in normal as well as tumor human sam-
ples, ERα colocalizes with β1-integrin fundamentally in tumors. 
These data are consistent with studies showing that high lev-
els of FN and β1-integrin in breast tumors are associated with 
lower survival (Yao et al., 2007; Helleman et al., 2008). More-
over, clinical data of breast cancer patients from TCGA databases 
show that alterations in ERα and β1-integrin genes are mutually 
exclusive, suggesting that they might be implicated in the same 
signaling pathway. In addition, alterations in these genes cor-
relate with decreased survival. The findings presented in this 
study have direct therapeutic implications for breast cancer as 
blocking FN-dependent activation of ERα, potentially by inhib-
iting the interaction between ERα and β1-integrin, arises as a 
novel target for new therapies. This would be a breakthrough 
approach to overcome endocrine resistance induced by the ECM 
in breast cancer.
Materials and methods
Cell culture
MCF7 and T47D cell lines were purchased from ATCC and reg-
ularly checked for mycoplasma. These cell lines were routinely 
maintained in DMEM/F12 cell culture medium (Sigma-Aldrich) 
supplemented with 10% FBS (Internegocios) and gentami-
cin, in a humidified 5% CO2/air atmosphere. Serial passages 
were performed by treatment of 80% confluent monolayers 
with 0.25% trypsin (Invitrogen) and 0.02% EDTA in Ca2+-free 
and Mg2+-free PBS.
Reagents
E2 was purchased from Sigma-Aldrich; BAF and BSA from Santa 
Cruz Biotechnology; and FN from EMD Millipore. Filipin and 
PAO, both from Sigma-Aldrich, were provided by C. Davio (Uni-
versidad de Buenos Aires, Buenos Aires, Argentina). BZ was pur-
chased from Velcade; Lipofectamine 2000 from Thermo Fisher 
Scientific; LyoVec transfection reagent InvivoGen; phalloidin 
from Sigma-Aldrich, and DAPI from Research Organics.
DNA constructs and RNA interference sequences
GFP-Rab7 expression construct was a gift from C. Arregui (Uni-
versidad de San Martin, Buenos Aires, Argentina; Hernández et 
al., 2006). Plasmid pTK-ERE-luc containing five copies of the ERE 
upstream of the luciferase cassette was a gift from C. Jordan (Uni-
versity of Texas, Houston, TX). pTK-renilla was purchased from 
Promega.The constructs were verified by sequencing. siRNA/
Stealth against ERα was purchased from Invitrogen as the follow-
ing sequences: sense 5′-CAG AGG CUC UCA AAC UAU AAA GAAA-3′, 
and antisense 5′-UUU CUU UAU AGU UUG AGA GCC UCUG-3′. siRNA 
against caveolin 1 (sc-29241), siRNA against clathrin–heavy chain 
(HC; sc-35067), and scrambled siRNA (sc-37007) were purchased 
from Santa Cruz Biotechnology.
Antibodies
The following antibodies were used in this study and were pur-
chased from Santa Cruz Biotechnology unless otherwise noted 
(including dilutions/amounts used for immunofluorescence, 
Western blot [WB], and immunoprecipitation [IP]): ERα (HC-20 
rabbit; 1:100 immunofluorescence, 1:200 WB; 3 µg IP), ERα (F-10 
mouse; 3 µg IP), β1-integrin (LM534 mouse; 1:100 immunofluores-
cence; EMD Millipore), β1-integrin (M-106 rabbit; 1:300 WB; 3 µg 
IP), E-cadherin (H-108 rabbit; 1:1,000 WB), β-actin (C4 mouse; 
1:10,000 WB), Rab11 (H-87 rabbit; 1:200 WB), Rab7 (sc-376362 
mouse; 1:100 immunofluorescence), and caveolin 1 (sc-53564 
Figure 9. Model for endocytic transport of ERα and β1-integrin regu-
lated by FN in breast cancer cells. Estrogens induce rapid endocytosis of 
membrane ERα–β1-integrin complexes, generating EEA1+ vesicles. In the 
absence of FN, vesicles containing β1-integrin and ERα could either fuse to 
the nuclear membrane where ERα exerts its action or follow the lysosomal 
pathway, where ERα colocalizes with Rab7. After 60 min, ERα and β1-integrin 
are degraded in lysosomes and the signal ends. In the presence of FN, ERα 
and β1-integrin are localized in Rab11+ vesicles, suggesting that they might 
be recycled and therefore avoid the lysosomal pathway. ERα and β1-integrin 
levels are maintained over time and the cycle continues, keeping ERα tran-
scriptionally active.
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mouse; 1:600 immunofluorescence; 1:200 WB). LAMP-1 (ab25630 
mouse; 1:20 immunofluorescence), clathrin (ab2731 mouse; 1:500 
immunofluorescence), and Lamin B1 (ab133741 rabbit; 1:243 
immunofluorescence) were purchased from Abcam; and clath-
rin-HC (clone 23 mouse; 610500; 1:1,000 WB) was purchased from 
BD. HC-20 peptide was purchased from Santa Cruz Biotechnology. 
Secondary antibodies used for WB (1:5,000) were goat anti–mouse 
HRP-conjugated (AP308P) and goat anti–rabbit HRP conjugated 
(AP132P) purchased from EMD Millipore. Secondary antibodies 
used for immunofluorescence (1:500) were goat anti–mouse and 
goat anti–rabbit Alexa Fluor 488–, 555–, and 647–conjugated anti-
bodies, all purchased from Thermo Fisher Scientific.
Subcellular fractionation
1,000,000 cells were seeded in 60-mm cell culture dishes 
(Greiner-Bio-One) coated with FN (2 µg/cm2 in PBS) in regular 
culture medium. Culture dishes coated with BSA (2 µg/cm2 in 
PBS) were used as control. After 16 h, cells were washed three 
times with PBS, and culture medium was changed to phenol 
red–free DMEM/F12 plus 1% charcoal-stripped FBS and left in 
the incubator for another 24  h. Cells were then treated with 
10−8 M E2 at 37°C for the indicated times and washed twice with 
PBS, and protein extracts were prepared by homogenizing fresh 
cells on ice in subcellular fractionation buffer (250 mM sucrose, 
20 mM Hepes, pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 
and 1 mM EGTA; Abcam). The Abcam subcellular fractionation 
protocol was followed. Briefly, cells were centrifuged at 720 g to 
obtain the nuclear pellet, and the supernatant was recentrifuged 
at 3,000  g to obtain the cytoplasmic and membrane fraction. 
After two further ultracentrifugations, cytosolic and membrane 
fractions were obtained. These fractions were subsequently ana-
lyzed by SDS-PAGE followed by Western blotting with the indi-
cated antibodies. Efficiency of nuclear/cytoplasmic separation 
was verified using nuclear-specific protein H2A.X (Fig. S5 e). 
E-cadherin was used to verify the efficiency of membrane puri-
fication (Fig. S1, g–j).
Western blot
Protein extracts from whole cells were prepared by scraping 
the culture dishes on ice with radioimmunoprecipitation assay 
(RIPA) buffer (50  mM Tris, pH 8.0, containing 150  mM NaCl, 
0.1% SDS, 0.5% deoxycholate, and 1% NP-40) containing prote-
ase inhibitors (40 µM phenylmethylsulfonyl fluoride, 5 µg/ml 
leupeptin, 50 µg/ml aprotinin, and 200  µM orthovanadate). 
Protein extracts form subcellular fractions were obtained as 
described above. Protein concentration was measured using the 
Bradford method (Bradford, 1976). After adding sample buffer 
containing β-mercaptoethanol, samples were heated at 95°C for 
5 min. 50 µg of each sample was then run in SDS-PAGE mini-
gels and transferred to polyvinylidene difluoride membranes 
(Amersham Biosciences). Membranes were blocked for 1 h at RT 
in 5% fat-free milk in Tris-buffered saline plus 0.1% Tween-20 
(TBST). Primary antibodies were prepared in blocking medium 
and incubated at 4°C overnight. After washing with TBST, mem-
branes were incubated with secondary antibodies for 1 h at RT. 
Signal was detected with an enhanced chemiluminescence kit 
(ECL; Amersham Biosciences). Densitometry was performed 
using the gel analyzer plugin of Fiji (ImageJ; National Institutes 
of Health; Schindelin et al., 2012) and the plugin Gels. The stan-
dard process with this software was to select the ROI in each 
lane individually and then plot the intensity measurements. 
The area under the curve was quantified, which represents the 
final intensity for each band. The intensities were further ana-
lyzed as has been extensively reported previously (Degasperi 
et al., 2014; McDonough et al., 2015). We then normalized each 
intensity value to the intensity measured for β-actin in the 
corresponding lane for each one of the three repetitions of the 
experiment. The three results for the density ratio of the con-
trol group were then averaged, and each ratio was normalized 
to the control mean, so that the control value will be 1 with its 
correspondent SD.
Membrane fluidity reduction, endocytosis/membrane 
recycling blockade, and lysosomal inhibition
For membrane fluidity reduction, a 15-min pretreatment of chill-
ing cells at 0°C followed by a treatment with E2 at 0°C or 37°C was 
performed. For endocytosis/membrane recycling blockade, fili-
pin (2.5 µg/ml), or PAO (5 µM) were administrated together with 
E2 for the indicated times. For lysosomal inhibition, a 90-min 
pretreatment with BAF (25 nM) at 37°C was done. After these 
treatments, subcellular fractionation and Western blot were per-
formed as described above.
Dextran endocytosis assay
We followed the protocol described previously for substrate 
endocytosis/recycling (Gillespie et al., 2013). Briefly, cells were 
seeded at 80% confluence in 24-well plates. After 16 h, cells were 
washed three times with PBS and serum-starved for 24 h. Cells 
were then treated with 10−8 M E2 or its vehicle for 15 min at 37°C. 
Then 10 µg/ml dextran-CF543 (80111; Biotium) was added, and 
cells were left at 37°C for another 10 min. Subsequently, cells 
were washed once with cold serum-free medium and twice 
with 0.2  M sodium acetate, pH 4.5, and washed again once 
with cold serum-free medium. For the chase, cells were incu-
bated another 15 min at 37°C with serum-free medium. After 
the chase, the medium was recovered before washing one more 
time with 0.2 M sodium acetate, pH 4.5. Fluorescence from acid 
washes and medium was measured on a FilterMax F3 Multi-
Mode Microplate-Reader (Molecular Devices) at 535/595-nm 
absorption/emission.
IP
The protocol described by Bonifacino et al. (2001) was followed 
with slight modifications. Briefly, fresh cells were lysed with 
weak RIPA buffer. 3 µg antibody was preincubated with protein 
A/G agarose beads (Santa Cruz Biotechnology) with gentle mix-
ing for 1 h at RT. Antibody–bead complexes were then mixed over-
night at 4°C with 500 µg protein. After several washes with weak 
RIPA, samples were analyzed by SDS-PAGE followed by Western 
blotting with the indicated antibodies.
Luciferase assay
100,000 cells per well were seeded in 48-well culture dishes 
coated or not coated with FN (2 µg/cm2) in the presence of 
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LyoVec–DNA complexes (50:1). DNA constructs pTK-Renilla and 
pTK-ERE-Luc were used in a 10:1 ratio. After 18  h, cells were 
washed three times with PBS, and culture medium was changed 
to phenol red–free DMEM/F12 plus 1% charcoal-stripped FBS 
and left in the incubator for another 24 h. Cells were then incu-
bated in the presence of 10−8 M E2 at 37°C for 14 h. Dual-luciferase 
reporter assay system kit (Promega) was used to reveal lucifer-
ase or renilla signals, following the instructions described by 
the manufacturer.
Immunofluorescence and confocal microscopy
50,000 cells were seeded on glass coverslips (Marienfeld) in 
24-well plates coated with BSA or FN (2 µg/cm2) in regular cul-
ture medium. After 16 h, cells were washed three times with PBS, 
and culture medium was changed to phenol red–free DMEM/F12 
plus 1% charcoal-stripped FBS and left in the incubator for 24 h. 
Cells were then treated with 10−8 M E2 for the indicated times. 
When cells were transfected before this treatment, 3 × 104 cells 
were seeded on glass coverslips in 24-well plates covered or uncov-
ered with FN (2 µg/cm2) in regular culture medium. After 16 h, 
cells were transfected using Lipofectamine 2000, following the 
protocol described by the manufacturer. Briefly, culture medium 
was replaced by OptiMEM (Thermo Fisher Scientific), and cells 
were incubated for 24 h with lipofectamine–DNA (5:1) complexes. 
Treatment was then administered as described above. For immu-
nofluorescence staining, the protocol described by Debnath et al. 
(2003) was followed with slight modifications. In brief, cells were 
fixed for 20 min at RT with 4% PFA in PBS and permeabilized 
with 0.1% Triton X-100 in PBS for 10 min at 4°C, then blocked for 
90 min at RT with immunofluorescence buffer (130 mM NaCl, 
7 mM Na2HPO4, 3.5 mM NaH2PO4, 7.7 mM NaN3, 0.1% BSA, 0.2% 
Triton X-100, and 0.05% Tween-20) plus 10% goat serum. They 
were subsequently stained with the indicated primary antibodies 
(prepared in blocking medium) overnight at 4°C, followed by incu-
bation with the secondary antibodies for 1 h at RT. For β1-integrin 
staining, when indicated, cells were live-stained: antibody was 
prepared in the culture medium, and cells were incubated with it 
for 1 h in the incubator. They were subsequently fixed and further 
stained as described above. For β1-integrin endocytosis assay, after 
live-staining, cells were treated with 10−8 M E2 for 15 min and then 
fixed and permeabilized with 0.1% Triton X-100 in PBS for 20 min 
at 37°C. Secondary antibodies were incubated for 1 h at RT. Covers-
lips were mounted using Mowiol 4–88 (Sigma-Aldrich). Widefield 
images were acquired using a Nikon Eclipse TE 2000-S inverted 
microscope with a Nikon Plan Fluor 20×/0.50-NA objective at 
RT using a Nikon Digital Sight DS-Fi1 camera and the acquisition 
software NIS-Elements (Nikon) and processed with Fiji. Confocal 
images were acquired using an Olympus FV-1000 inverted confo-
cal microscope with an Olympus 60×/1.20-NA UPL AN Apochro-
mat water objective, at RT, using the acquisition software Olympus 
FluoView v.5.0 and processed with Fiji. For colocalization analyses, 
PCCs and MCCs were calculated within the desired areas of the 
images as described previously (Dunn et al., 2011). Briefly, PCC is a 
useful statistic to quantify colocalization, with values range from 
1 for two images whose fluorescence intensities are perfectly and 
linearly related to −1 for two images whose fluorescence intensi-
ties are perfectly but inversely related to one another. Values near 
zero reflect distributions of probes that are uncorrelated with one 
another. In the images shown, red color indicates a value of 1 for 
the PCC, and blue indicates a value of −1. The formula for PCC for 
a typical image consisting of red and green channels is
 PCC =   ∑ i   ( R i −  ¯  R ) ×  ( G i −  ¯  G )   ___________________   ∑ i   ( R i −  ¯  R ) 2 ×  ∑ i   ( G i −  ¯  G ) 2 , 
where Ri and Gi refer to the intensity values of the red and green 
channels, respectively, of pixel i, and R̄ and Ḡ refer to the mean 
intensities of the red and green channels, respectively, across the 
entire image. We calculated it for each analyzed frame using the 
Colocalization colormap plugin for Fiji. Although PCC provides 
an effective statistic for measuring overall association of two 
probes in an image, MCC is useful to measure the fraction of one 
protein that colocalizes with a second protein. For two probes, 
denoted as R and G, two different MCC values are derived, M1, the 
fraction of R in compartments containing G, and M2, the fraction 
of G in compartments containing R. These coefficients are sim-
ply calculated as
 M 1 =  
 ∑ i   R i,colocal  _ ∑ i   R i  , 
where Ri,colocal = Ri if Gi > 0 and Ri,colocal = 0 if Gi = 0 and
 M 2 =  
 ∑ i   G i,colocal  _ ∑ i   G i  , 
where Gi,colocal = Gi if Ri > 0 and Gi,colocal = 0 if Ri = 0. We calcu-
lated these coefficients for each analyzed frame using the Coloc 
2 plugin for Fiji.
3D rendering from z stacks was performed using Fiji and the 
plugin 3D Viewer. This plugin performs the 3D reconstitution from 
which we recorded the videos and images shown in this paper.
Verification of antibody specificity
Every antibody used in this paper was chosen based on its wide 
usage in the literature. In particular, the antibody used to detect 
ERα has been used in >200 papers (Gao et al., 2015; Arnal et 
al., 2017). β1-integrin antibodies used throughout this paper 
have also been widely used in the literature (Tiwari et al., 2011; 
Waxmonsky and Conner, 2013; Long et al., 2016). In the case of 
the antibody used to detect ERα, the most thoroughly used in 
the present paper, its specificity was tested for Western blot and 
immunofluorescence. For immunoneutralization assays, ERα 
antibody (clone HC-20; Santa Cruz Biotechnology) was preincu-
bated for 90 min at 4°C with HC-20 peptide (Santa Cruz Biotech-
nology) or its control before using it in the blotting membranes 
from MCF7 cell lysates or for immunofluorescence of these cells. 
Considering that each antibody has two HC-20 epitopes and that 
an excess (at least 10-fold) of the peptide is needed to ensure 
efficient blocking (Skliris et al., 2009), the amount of blocking 
peptide used was calculated as
 mol HC-20 peptide =  [ 2 ∗  ( mol ERα antibody ) ] ∗ 10. 
However, the specificity of this antibody was further confirmed 
by knocking down endogenous ERα in MCF7 cells, with the spe-
cific siRNA described above, followed by its detection through 
Western blot to evaluate the loss of the ERα signal.
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TIR FM
This technique is based in the formation of  an evanescent 
electromagnetic field generated when the incident light is 
totally internally reflected at the glass–water interface. The 
evanescent field decays exponentially from the interface and 
thus only illuminates fluorophores that are close to the glass. 
Therefore, it is used to selectively detect molecules localized 
in the ventral plasma membrane, within a radius of ∼100 nm 
from the glass surface (Ambrose, 1956; Axelrod, 1981, 2001). 
300,000 cells were seeded on BSA- or FN-coated (2 µg/cm2) 
25-mm coverslips in six-well plates. After 16  h, cells were 
live-stained for β1-integrin as explained for confocal micros-
copy, or fixed with 4% PFA/4% sucrose and stained with the 
antibody against ERα. Coverslips were mounted in PBS on the 
stage of a fully motorized Nikon TE2000-E inverted micro-
scope equipped for widefield and TIR FM. In all cases, cells 
were visualized through a TIRF 60×/1.45-NA water objective, 
at RT, and imaged using an ORCA II ER charge-coupled device 
(CCD) camera controlled by the MetaMorph software (Molec-
ular Devices). Images were then processed with the software 
Fiji. For TIR FM, cells were illuminated using a 488-nm argon 
laser. Evanescent wave penetration depth was calculated to 
be ∼210 nm using the following parameters: 488 nm as λ, 
1.52 as n1, 1.33 as n2, and 62° as the incident light beam angle. 
For image processing, when indicated, polar transformation 
was performed using Fiji and the plugin Polar Transformer 
(https:// imagej .nih .gov/ ij/ plugins/ polar -transformer .html). 
This transformation takes an input image in a Cartesian space 
and transforms it into polar coordinates. This transformation 
is useful for “unwrapping” images with a generally round 
object. As a consequence of this transformation, if  the image 
has a visible background, the four angles of the original can 
be often seen as four triangle-like shapes to the right of the 
transformed image (giving rise to five black arches, which is 
the color of the underlying background).
STO RM
Setup
The STO RM microscope is custom-built on an Olympus IX-73 
inverted microscope. Two continuous-wave lasers of wavelength 
642 nm (2RU-VFL-P-1500-642; MPB Communications) and 532 
nm (Ventus 532; Laser Quantum) and output power of 1.5 W are 
used for fluorescence excitation/deactivation (van de Linde et 
al., 2011), and a 405-nm continuous-wave, 50-mW laser (RGB 
Photonics Lambda Mini) is used for fluorescence reactivation. 
The lasers are combined with dichroic mirrors (LM01-552-25 
and LM01-427-25; Semrock), magnified, and then focused to the 
back focal plane of the oil-immersion objective Olympus Plan 
Apochromat 60× NA 1.42. A multiband dichroic mirror (Di03-R 
405/488/532/635-t1 25 × 36; Semrock) is used for decoupling 
of the fluorescence emission of the sample from the laser exci-
tation. Further blocking of the illumination lasers is performed 
with a multi-edge notch filter (NF03-405/488/532/635E-25; 
Semrock). The emission light is further divided into two chan-
nels with a longpass dichroic (zt647rdc; Chroma) and expanded 
with a 2× telescope so that the pixel size of the electron-multi-
plying CCD camera (Andor iXon3 897) matches an optimal value 
for single-molecule localization, in this case a pixel size of 133 
nm. Both channels are filtered with appropriate emission dichro-
ics for Alexa Fluor 565 and 647 (Semrock 582/75 BrightLine HC 
and Chroma ET700/75m) and imaged side by side into the same 
electron-multiplying CCD camera (Andor ixon3 897) by using a 
D-shaped mirror.
A motorized platform is used to laterally displace the illumi-
nation (two mirrors and lens), focusing at the back focal plane 
of the objective. This allows to switch among conventional 
widefield, HILO, and TIRF illumination. To prevent defocusing 
within the relatively long STO RM imaging acquisition, the setup 
is equipped with a custom-built focus stabilization system that 
senses the total internal reflection of an IR diode laser at the 
interface between the coverslip and the sample and then actu-
ates by mechanically correcting the objective’s axial position. The 
camera, lasers, motorized parts of the microscope, and focus sta-
bilization system are controlled and integrated with Tormenta, 
open-source, free Python software for fluorescence microscopy 
control and measurements (Barabas et al., 2016).
Data acquisition
Cells cultured on 18-mm coverslips were placed in a holder, and 
imaging was performed in 50 mM Tris, pH 8, 10 mM NaCl buf-
fer, at RT. The imaging buffer was supplemented with 10% wt/vol 
glucose, 100 mM 2-mercaptoethylamine, 1 µg/ml glucose oxidase 
(Sigma-Aldrich), and 0.5 µg/ml catalase (Sigma-Aldrich) as oxy-
gen scavenging system.
Before STO RM imaging, conventional fluorescence images of 
the ROI were acquired by setting the excitation laser intensity to 
1–5 W cm−2. STO RM data acquisition was then started by chang-
ing the excitation lasers’ intensity to 5–15 kW cm−2, thus inducing 
on-off switching of the fluorescent marker in the tens of milli-
seconds time range. A camera rate of 20 Hz was found appropri-
ate considering both Alexa Fluor 647 and 565 switching times. 
Throughout the whole acquisition, the activation 405-nm laser 
power (1–10 µW cm−2) was increased manually in steps when-
ever the density of single-molecule events decreased below ∼1–2 
molecules per frame. Typically, 15,000 frames were recorded to 
assure a high density of localizations.
To correct for chromatic aberrations, the two channels were 
calibrated using fluorescent nanoparticles emitting in both 
channels (TetraSpeck microspheres; Thermo Fisher Scientific). 
An affine matrix was computed as the best transformation that 
matches the location of the beads in both channels (Hartley and 
Zisserman, 2004). Only calibrations resulting in an error <10 nm 
were used. A preprocessing background subtraction step is per-
formed to match the background level of both channels for sub-
sequent analysis. The localization analysis and the rendering of 
the final superresolved image were performed with ThunderSTO 
RM software (Ovesný et al., 2014).
Data analysis
MatLab software (release 2014a; MathWorks) was used to ana-
lyze all the images using codes developed by our laboratory to 
study distribution of distances, densities, and architecture of 
the proteins imaged by STO RM as described for each corre-
sponding figure. 
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Human breast tissues
Breast tissues from reduction mammoplasties and tumors were 
acquired from the Cooperative Human Tissue Network, a pro-
gram funded by the National Cancer Institute. All specimens 
were collected with patient consent; reduction mammoplas-
ties were reported negative for proliferative breast disease by 
board-certified pathologists. Use of anonymous samples was 
granted exemption status by the University of California, Berke-
ley, Institutional Review Board in accordance with the Code of 
Federal Regulations 45 CFR 46.101.
Statistical analysis
All statistical analyses were performed using SPSS (IBM SPSS 
Statistics for Mac OS X, v.23.0; IBM Corp.) or Prism 5 (v.5.0c for 
Mac OS X; GraphPad Software). To detect differences between 
media, we used Student’s t test when comparing between two 
media. For multiple contrasts, we used two-way ANO VA followed 
by Bonferroni contrast adjusted for multiple comparisons. Statis-
tical tests and the corresponding contrasts used for each assay are 
indicated in the figure legends.
Online supplemental material
Fig. S1 shows that FN stabilizes ERα and verifies specificity of 
the antibodies used. Fig. S2 provides further evidence that ERα is 
endocytosed in the presence of E2. Fig. S3 confirms that ERα and 
β1-integrin colocalize at the plasma membrane and are internal-
ized upon treatment with E2 in both MCF7 and T47D cells. Fig. S4 
shows the conditional distribution of ERα and β1-integrin and its 
statistical properties from superresolution microscopy analyses. 
Fig. S5 shows the nuclear localization of ERα through STO RM and 
provides evidence for ERα+ endosomes in human breast tissues 
using the antibody typically used for clinical analysis (clone SP1). 
Video 1 provides a 3D render to show that ERα and β1-integrin 
colocalize in membrane structures in breast tumor cells.
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Figure S1. FN stabilizes ERα. (a) Confocal images of MCF7 cells seeded on BSA or FN treated with E2 for 15 min and stained for ERα. (b) Quantification of 
a. For each experimental condition, shown is nuclear ERα intensity (mean gray value) per cell calculated using Fiji relative to the highest intensity recorded. 
Differences between groups were analyzed by one-tailed Student’s t test (per replicate: BSA: nBSA = 8 cells; nFN = 15 cells). (c and d) Western blots of a sub-
cellular fractionation of T47D cells seeded on BSA and treated for 15 (c) or 60 min (d) as indicated. Blotting antibodies are shown on the left. For each subcel-
lular fraction, shown is the ERα/β-actin density ratio normalized to the control group. (e and f) Western blots of a subcellular fractionation of T47D cells 
seeded on FN and treated for 15 (e) or 60 min (f) as indicated. Blotting antibodies are shown on the left. For each subcellular fraction, shown is the ERα/β-
actin density ratio normalized to the control group. (g and h) Western blots of a subcellular fractionation of MCF7 cells seeded on BSA and treated for 15 (g) 
or 60 min (h) as indicated. Blotting antibodies are shown on the left. For the membrane fraction, the ERα/E-cadherin density ratio is shown normalized to 
the control group. For the cytoplasmic fraction, shown is the ERα/β-actin density ratio normalized to the control group. (i and j) Western blots of a subcel-
lular fractionation of MCF7 cells seeded on FN and treated for 15 (i) or 60 min (j) as indicated. Blotting antibodies are shown on the left. For the membrane 
fraction, the ERα/E-cadherin density ratio is shown normalized to the control group. For the cytoplasmic fraction, shown is the ERα/β-actin density ratio 
normalized to the control group. (k) Confocal images of T47D cells expressing GFP-Rab7 seeded on BSA (top) or FN (bottom), treated for 15 min as indicated, 
and stained for ERα. Pearson's correlation maps are shown on the right. (l) Confocal images of MCF7 cells, seeded on BSA or FN, treated for 60 min as indi-
cated, and stained for LAMP-1 or ERα. Arrows indicate regions of colocalization between the two markers. (m) Western blots of MCF7 cells blotted with ERα 
antibody (clone HC-20) preincubated for 90 min at 4°C with HC-20 peptide or its control before using it in the blotting membranes following the standard 
protocol for Western blot. (n) Widefield images of T47D cells stained with ERα antibody preincubated with HC-20 peptide or its control. Counterstaining, 
DAPI. (o) Western blots of ERα knockdown by siRNA in MCF7 cells. Blotting antibodies are shown on the left. Data are represented as mean ± SD. ***, P < 
0.001. Shown data are representative of at least three independent experiments. Black arrowheads indicate positions of 50-kD markers. White arrowheads 
indicate positions of 100-kD markers. Treatments: ethanol (vehicle) or 10−8 M E2. Bars, 10 µm (unless otherwise indicated).
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Figure S2. ERα is endocytosed in the presence of E2. (a) Confocal images of MCF7 cells treated for 15 min as indicated and stained for EEA1 or ERα. Arrows 
indicate regions of colocalization between the two markers. (b) Confocal images of MCF7 cells treated for 15 min as indicated and stained for Lamin B1 or 
EEA1. Arrow indicates regions of colocalization between the two markers. White rectangles outline the areas whose magnifications are presented in the 
bottom panels, showing each channel separately and their corresponding merge. Pearson’s correlation maps are shown on the bottom right. Arrows indicate 
regions of colocalization between the two markers. (c) 3D reconstruction from confocal z stacks of MCF7 cells treated for 15 min with E2 and stained for EEA1 
or propidium iodide (PI). Top: Rendered image of a side view of the cell outlined with a yellow rectangle in the inset. Bottom left: Rendered image of the top 
view of the outlined cell. Bottom right: Rendered image of the bottom view of the outlined cell. Renderizations were done using the plugin 3D viewer of Fiji. 
The inset shows the full reconstructed field. (d) Left: Outline of the protocol followed and Western blot of a subcellular fractionation of MCF7 cells treated 
as indicated. Blotting antibodies are shown on the left. Right: Densitometry. For each subcellular fraction, the ERα/β-actin density ratio is shown, normalized 
to the mean control group. Each symbol represents a different experiment. Differences between groups were analyzed by one-tailed paired Student’s t test 
(n = 3). (e) Images of confocal microscopy of the nuclear/cytoplasmic (apical) focal plane (z1) of MCF7 cells seeded on BSA or FN treated for 15 min as indi-
cated and stained for ERα. White arrows indicate ERα+ vesicles, determined as punctae of 10–15 pixels in diameter (∼200 nm). (f) MCF7 cells were treated 
with E2 for the indicated times, in the presence of dextran-CF543. Differential interference contrast (DIC) images merged with the red channel (dextran) are 
shown. (g) Images of confocal microscopy of MCF7 cells treated with E2 for the indicated times in the presence of dextran-CF543 and stained for EEA1. Ar-
rows indicate regions of colocalization between the two fluorophores. (h) Quantification of g. For each experimental condition, the number of dextran+ en-
dosomes per cell is shown after a 15-min treatment. Differences between groups were analyzed by one-tailed Student’s t test (per replicate: n = 9 fields). 
(i) Dextran recycling assay. MCF7 cells seeded on BSA or FN were pretreated for 15 min with E2 or its vehicle, followed by a 10-min incubation with dex-
tran-CF543, and then were chased for 15 min to measure the amount of dextran-CF543 in the conditioned medium. For each experimental condition, shown 
is the fluorescence intensity measured for three independent experiments. Data are represented as mean ± SD. Differences between groups were analyzed 
by one-tailed paired Student’s t test (n = 3 replicates). *, P < 0.05; ***, P < 0.001. Shown data are representative of at least three independent experiments. 
Black arrowheads indicate positions of 50-kD markers. White arrowheads indicate positions of 37-kD markers. Treatments: ethanol (vehicle) or 10−8 M E2, 
10 µg/ml dextran-CF543. Bars, 10 µm.
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Figure S3. ERα and β1-integrin colocalize at the plasma membrane and are internalized after treatment with E2. (a) Confocal images of T47D cells 
stained for ERα and β1-integrin. Pearson’s correlation map is shown on the right. Right: Quantification. For each experimental condition, Pearson’s correla-
tion index was calculated within the areas of colocalization (ROI) and compared with random areas without colocalization (Null), using Fiji. Differences be-
tween groups were analyzed by one-tailed Student’s t test (per replicate: nnull = 3 fields, nROI = 3 fields). (b) TIR FM images of MCF7 cells stained for pFAK and 
β1-integrin. Polar transformation performed with Fiji is shown on the right. Right: Quantification. For each experimental condition, Pearson’s correlation 
index was calculated within the areas of colocalization (ROI) and compared with random areas without colocalization (Null), using Fiji. Datasets are plotted, 
and mean ± SD are shown on the graph. Differences between groups were analyzed by one-tailed Student’s t test (per replicate: nnull = 4 fields, nROI = 4 fields). 
(c) Western blot of a coimmunoprecipitation assay on MCF7 cells. IP antibodies are shown on the top. Blotting antibodies are shown on the right. Input, 
whole lysate; IP, immunoprecipitated fraction; Sn, supernatant fraction from the IP. (d) Left: IP experiment following the protocol described by Bonifacino et 
al. (2001) with slight modifications. Immunoblot: β1-integrin (1981-LM534). The specific band corresponding with β1-integrin upon IP with ERα (F10) anti-
body, and blotted with β1-integrin LM534 antibody can be seen. As expected, IP with control IgG does not show the specific β1-integrin band. Lanes: IP, ERα 
antibody; Sn1, supernatant from IP with ERα antibody; IP-IgG, control IgG; Sn2, supernatant from IP with control IgG. Right: Improved IP protocol adding 
more stringent washing conditions to remove the remaining IP primary antibodies, leading to cleaner IPs. Immunoblot: β1-integrin. This blot is one of the 
replicates of the original Western blot shown in c. The specific, albeit faint, β1-integrin band can be seen in the IP lane, whereas this band is absent in the lane 
from control IgG. Lanes: IP, ERα antibody; IP-IgG, control IgG. Arrows indicate the band corresponding with β1-integrin. (e) Top: Western blot of total lysates 
of T47D cells seeded on BSA and treated for 60 min as indicated. Blotting antibodies are shown on the left. Bottom: Densitometry. For each experimental 
condition, shown is the β1-integrin/β-actin density ratio normalized to the mean control group. Each symbol represents a different experiment. Differences 
between groups were analyzed by one-tailed paired Student’s t test (n = 3 replicates). (f) Top: Western blot of total lysates of T47D cells seeded on FN and 
treated for 60 min as indicated. Blotting antibodies are shown on the left. Bottom: Densitometry. For each experimental condition, shown is the β1-integ-
rin/β-actin density ratio normalized to the mean control group. Each symbol represents a different experiment. Differences between groups were analyzed 
by one-tailed paired Student’s t test (n = 3 replicates). (g) Widefield images of MCF7 cells live-stained for β1-integrin and then treated for 15 min as indicated 
to chase β1-integrin internalization dynamics. Arrows indicate β1-integrin+ vesicles determined as punctae of ∼200-nm diameter (10–15 pixels). (h) Quanti-
fication of g. For each experimental condition, shown is the number of β1-integrin+ vesicles per cell, among cells with these endosomes. Shown data are 
mean ± SD. Differences between groups were analyzed by one-tailed Student’s t test (per replicate: n = 5 fields). (i) Top: Western blot of total lysates of 
MDA-MB-231 cells (human mammary adenocarcinoma) seeded on BSA and treated for 60 min as indicated. Blotting antibodies are shown on the left. Bot-
tom: Densitometry. For each experimental condition, shown is the β1-integrin/β-actin density ratio normalized to the mean control group. Each symbol 
represents a different experiment. Differences between groups were analyzed by one-tailed paired Student’s t test (n = 3 replicates). (j) Top: Western blot of 
total lysates of HeLa cells (human cervical cancer) seeded on BSA and treated for 60 min as indicated. Blotting antibodies are shown on the left. 
Bottom: Densitometry. For each experimental condition, shown is the β1-integrin/β-actin density ratio normalized to the mean control group. Each symbol 
represents a different experiment. Differences between groups were analyzed by one-tailed paired Student’s t test (n = 3 replicates). *, P < 0.05. Shown data 
are representative of at least three independent experiments. Black arrowheads indicate positions of 100-kD markers. White arrowheads indicate positions 
of 50-kD markers. Treatments: ethanol (vehicle) or 10−8 M E2. Bars, 10 µm (unless otherwise indicated).
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Figure S4. Conditional distribution of ERα versus β1-integrin and its statistical properties. (a) Shown is the histogram for normalized frequencies for 
the MDs between β1-integrin and ERα in filopodia of MCF7 cells among all the analyzed fields from STO RM images. For each domain detected, centroids 
were identified, and MDs were calculated from each β1-integrin to its nearest ERα domain throughout each 500 × 500-pixel frame. Frequency of each dis-
tance bin was normalized to the highest frequency detected. The graph shows that the mean MD between ERα and β1-integrin is ∼100 nm. (b) Shown is the 
mean density covariance between ERα and β1-integrin domains. Each frame was divided into square ROIs of different sizes as depicted in c. Within each 
window, the density of ERα or β1-integrin was computed, and the correlation coefficient (C) between these densities was calculated for each frame analyzed. 
The mean of C among all the analyzed cells (black full circles) or randomized data generated by mixing β1-integrin images with random ERα images (violet 
empty triangles) was plotted as a function of the window side length. The inset shows the z score. It was calculated as the difference between the mean of 
the original dataset for each window minus the mean of the randomized group divided by the square root of the sum of the SD of each group normalized by 
n. This result shows a significant difference in density covariance between both groups, indicating that ERα and β1-integrin have a positive spatial association 
and that this organization is not a consequence of a random process. (c) Each 500 × 500–pixel field was divided into squares or windows of different sizes 
(from 130 nm [10 pixels] to 2,000 nm [150 pixels] in side length) to evaluate ERα and β1 intensities in each window. The figure shows one field divided into 
50 × 50–pixel windows and colored as a function of the ratio between ERα and β1-integrin densities, going from 0 to 1 as shown in the color bar on the right. 
(d) Each color represents a different ERα or β1-integrin domain from the STO RM fields of filopodia of MCF7 cells shown on the top right corners. (e) Rank 
size distribution plot of the domains depicted in d. From the largest sizes on the left and decreasing to the right of the plot, the empty symbols represent 
averages over 10 frames denoted by crosses. A simple visual inspection already reveals no significant differences between the datasets obtained under vehi-
cle (upper) or treated (bottom) conditions. (f) Box plots representing the total number of domains identified among all the analyzed fields for ERα or β1- 
integrin in control or E2-treated cells. Central red marks represent the median, and the bottom and top edges of each box indicate the 25th and 75th percen-
tiles, respectively. The whiskers extend to the most extreme data points. This plot shows no significant differences in the number of domains between control 
and treated cells. Student’s t test (n = 3 replicates). Shown data are representative of at least three independent experiments. Treatments: ethanol (vehicle) 
or 10−8 M E2. Bars, 2 µm.
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Figure S5. Nuclear distribution of ERα and colocalization with β1-integrin in human breast samples. (a) Images from STO RM of the nuclear region of 
MCF7 cells treated as indicated for 15 min and stained for ERα or β1-integrin. Insets in the top left corners show the same images taken with widefield mi-
croscopy. Blue squares outline representative areas of 500 × 500 pixels used for subsequent analysis. (b) Box plot representing the total number of centroids 
(domains) identified among all the analyzed nuclear fields for ERα in control or E2-treated cells. Central red mark represents the median, and the bottom and 
top edges of the box indicate the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme data points. This plot shows that E2 treat-
ment significantly increases the number of ERα nuclear domains compared with control. Student’s t test (n = 3 replicates). (c) Top: Confocal images of a 
normal human breast tissue (reduction mammoplasty; sample N211) stained for ERα (SP1 clone), β1-integrin, and DAPI. Arrows indicate the presence of ERα+ 
endosomes. Similar results were obtained in the four different specimens analyzed. Bottom: Confocal images of a human breast tumor (Luminal A subtype 
adenocarcinoma; sample T171) stained for ERα (SP1 clone), β1-integrin, and DAPI. Arrows indicate the presence of ERα+ endosomes. Similar results were 
obtained in the three different specimens analyzed. (d) Table showing mean and SD of Pearson’s correlation index calculated for the overall colocalization 
between ERα and β1-integrin. Differences between groups were analyzed by two-tailed Student’s t test (per replicate: nnormal = 6 fields; ntumor = 6 fields). 
(e) Western blot of a subcellular fractionation of MCF7 cells, seeded on BSA and treated for 60 min as indicated. Blotting antibodies are shown on the left. 
**, P < 0.01. Shown data are representative of at least three independent experiments. Black arrowheads indicate positions of 50-kD markers. White arrow-
heads indicate positions of 20-kD marker. Treatments: ethanol (vehicle) or 10−8 M E2.
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Video 1. ERα and β1-integrin colocalize in membrane structures. Fiji 3D-reconstruction of confocal images of a cell (MCF7) 
stained for ERα and β1-integrin. Frame rate: seven frames per second.
